Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Merck & Co., Inc. (MRK)

108.45   0.95 (0.88%) 11-28 16:03
Open: 107.125 Pre. Close: 107.5
High: 108.9 Low: 107.125
Volume: 9,212,152 Market Cap: 274,964(M)

Technical analysis

as of: 2022-11-28 4:41:38 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 127.18     One year: 148.55
Support: Support1: 101.09    Support2: 96.26
Resistance: Resistance1: 108.89    Resistance2: 127.18
Pivot: 102.98
Moving Average: MA(5): 107.06     MA(20): 102.15
MA(100): 92.45     MA(250): 86.79
MACD: MACD(12,26): 3.2     Signal(9): 2.7
Stochastic oscillator: %K(14,3): 97.1     %D(3): 97.2
RSI: RSI(14): 75.8
52-week: High: 108.89  Low: 71.5
Average Vol(K): 3-Month: 8,924 (K)  10-Days: 7,793 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ MRK ] has closed below upper band by 7.6%. Bollinger Bands are 87.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 109.03 - 109.43 109.43 - 109.76
Low: 106.03 - 106.54 106.54 - 106.96
Close: 107.68 - 108.47 108.47 - 109.11

Company Description

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Headline News

Mon, 28 Nov 2022
Wall Street Loves These 4 "Strong Buy" Stocks Right Now - Nasdaq

Mon, 28 Nov 2022
Notable Monday Option Activity: MRK, V, FDX - Nasdaq

Mon, 28 Nov 2022
MRK: 3 Stocks Insiders Can't Stop Buying This Month - StockNews.com

Sun, 27 Nov 2022
Is Merck & Co., Inc. (NYSE:MRK) Trading At A 48% Discount? - Simply Wall St

Fri, 25 Nov 2022
Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication - Yahoo Finance

Tue, 22 Nov 2022
Buy These 5 Corporate Giants Flying High in Disappointing 2022 - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. 2,530 (M)
Shares Float 2,530 (M)
% Held by Insiders 0.1 (%)
% Held by Institutions 76 (%)
Shares Short 19,240 (K)
Shares Short P.Month 19,450 (K)

Stock Financials

EPS 2.76
EPS Est Next Qtl 0.95
EPS Est This Year 3.86
EPS Est Next Year 4.15
Book Value (p.s.) 10.01
Profit Margin (%) 29
Operating Margin (%) 34.9
Return on Assets (ttm) 12.6
Return on Equity (ttm) 43.4
Qtrly Rev. Growth 28
Gross Profit (p.s.) 14.01
Sales Per Share 22.59
EBITDA (p.s.) 9.28
Qtrly Earnings Growth 154.1
Operating Cash Flow 18,890 (M)
Levered Free Cash Flow 10,300 (M)

Stock Valuations

PE Ratio 39.15
PEG Ratio 1.2
Price to Book value 10.83
Price to Sales 4.79
Price to Cash Flow 14.52

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-01-06
Ex-Dividend Date 2021-12-13
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.